Follow
Gabriele Zoppoli
Gabriele Zoppoli
University of Genoa and IRCCS Policlinico San Martino
Verified email at unige.it - Homepage
Title
Cited by
Cited by
Year
Genomic characterization of primary invasive lobular breast cancer
C Desmedt, G Zoppoli, G Gundem, G Pruneri, D Larsimont, M Fornili, ...
Journal of clinical oncology 34 (16), 1872-1881, 2016
2982016
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
G Zoppoli, M Regairaz, E Leo, WC Reinhold, S Varma, A Ballestrero, ...
Proceedings of the National Academy of Sciences 109 (37), 15030-15035, 2012
2932012
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
M Piccart, LJ van't Veer, C Poncet, JMNL Cardozo, S Delaloge, JY Pierga, ...
The Lancet Oncology 22 (4), 476-488, 2021
2262021
Fasting-mimicking diet and hormone therapy induce breast cancer regression
I Caffa, V Spagnolo, C Vernieri, F Valdemarin, P Becherini, M Wei, ...
Nature 583 (7817), 620-624, 2020
2262020
Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE
S Bruzzone, F Fruscione, S Morando, T Ferrando, A Poggi, A Garuti, ...
PloS one 4 (11), e7897, 2009
2032009
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses
I Bauer, A Grozio, D Lasigliè, G Basile, L Sturla, M Magnone, G Sociali, ...
Journal of Biological Chemistry 287 (49), 40924-40937, 2012
1822012
Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
D Brown, D Smeets, B Székely, D Larsimont, AM Szász, PY Adnet, ...
Nature communications 8 (1), 14944, 2017
1582017
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
CE Geyer Jr, JE Garber, RD Gelber, G Yothers, M Taboada, L Ross, ...
Annals of oncology 33 (12), 1250-1268, 2022
1552022
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer
DN Brown, I Caffa, G Cirmena, D Piras, A Garuti, M Gallo, S Alberti, ...
Scientific reports 6 (1), 19435, 2016
1282016
Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1 …
AG Jobson, GT Lountos, PL Lorenzi, J Llamas, J Connelly, D Cerna, ...
Journal of Pharmacology and Experimental Therapeutics 331 (3), 816-826, 2009
1122009
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin’s lymphoma patients treated with rituximab-containing regimens
D Bedognetti, G Zoppoli, C Massucco, E Zanardi, S Zupo, A Bruzzone, ...
The Journal of Immunology 186 (10), 6044-6055, 2011
1112011
Immune infiltration in invasive lobular breast cancer
C Desmedt, R Salgado, M Fornili, G Pruneri, G Van den Eynden, ...
JNCI: Journal of the National Cancer Institute 110 (7), 768-776, 2018
1042018
Genomic aberrations in young and elderly breast cancer patients
HA Azim, B Nguyen, S Brohée, G Zoppoli, C Sotiriou
BMC medicine 13, 1-7, 2015
1042015
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
TL Spivey, L Uccellini, ML Ascierto, G Zoppoli, V De Giorgi, LG Delogu, ...
Journal of translational medicine 9, 1-22, 2011
1022011
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative
P Aftimos, M Oliveira, A Irrthum, D Fumagalli, C Sotiriou, EN Gal-Yam, ...
Cancer discovery 11 (11), 2796-2811, 2021
882021
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells
M Cea, D Soncini, F Fruscione, L Raffaghello, A Garuti, L Emionite, ...
PloS one 6 (7), e22739, 2011
872011
Uncovering the genomic heterogeneity of multifocal breast cancer
C Desmedt, D Fumagalli, E Pietri, G Zoppoli, D Brown, S Nik‐Zainal, ...
The Journal of pathology 236 (4), 457-466, 2015
832015
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity
D Soncini, I Caffa, G Zoppoli, M Cea, A Cagnetta, M Passalacqua, ...
Journal of Biological Chemistry 289 (49), 34189-34204, 2014
742014
Squalene epoxidase as a promising metabolic target in cancer treatment
G Cirmena, P Franceschelli, E Isnaldi, L Ferrando, M De Mariano, ...
Cancer letters 425, 13-20, 2018
692018
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response
J Roelands, W Hendrickx, G Zoppoli, R Mall, M Saad, K Halliwill, ...
Journal for immunotherapy of cancer 8 (1), 2020
652020
The system can't perform the operation now. Try again later.
Articles 1–20